Gapping up
In reaction to strong earnings/guidance:
- FL +14.9%, NWY +7.2%, LGF.A +7%, SCVL +5.9%, YRD +5%, DECK +4.7%, QSII +1%
Other news:
- CAVM +6% (Marvel announces completion of CFIUS review of previously announced merger transaction with Cavium; continues to expect the merger to close mid-calendar year of 2018)
- DGX +4.1% (UnitedHealth establishes long-term strategic partnerships with Quest Diagnostics and LabCorp)
- AMRN +3.6% (Amarin settles Vascepa patent litigation with Teva)
- MRVL +3.4% (Marvel announces completion of CFIUS review of previously announced merger transaction with Cavium; continues to expect the merger to close mid-calendar year of 2018)
- BMRN +2.7% (ticking higher; receives standard approval for Palynziq injection for treatment of adults with Phenylketonuria genetic disease)
- LEN +1.3% (following CNBC Fast Money mention)
- MUX +0.9% (McEwen Mining provides an updated mineral resource estimate for the Tamarack gold and base metal deposit at the 100% owned Black Fox Complex), .
Analyst comments:
- CYAD +3.5% (initiated with a Outperform at Wells Fargo)
- NVS +1% (upgraded to Neutral from Underperform at Credit Suisse)
![]()